SAB Biotherapeutics Appoints Michael G. King Jr. as Chief Financial Officer
Finance leader joins SAB with more than 25 years of experience as a leading biotech equity research analystSIOUX FALLS, S.D., Oct. 24, 2023 -- SAB Biotherapeutics, Inc. , today announced that...